Winner Medical Co., Ltd. (SHE:300888)
China · Delayed Price · Currency is CNY 29.69
-0.24 (-0.80%)
Oct 28, 2026, 9:45 AM CST
Winner Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,375 | 1,594 | 1,412 | 4,706 | 4,527 | 4,274 |
Short-Term Investments | - | 428.09 | 340.99 | - | 101.67 | 50.16 |
Trading Asset Securities | 3,749 | 2,825 | 2,921 | 2,850 | 4,379 | 3,131 |
Cash & Short-Term Investments | 5,124 | 4,847 | 4,674 | 7,556 | 9,007 | 7,455 |
Cash Growth | 33.05% | 3.70% | -38.14% | -16.11% | 20.83% | -10.12% |
Accounts Receivable | 1,287 | 1,133 | 1,088 | 845.29 | 1,077 | 785.49 |
Other Receivables | 201.57 | 204.47 | 186.35 | 218.91 | 236.3 | 329.18 |
Receivables | 1,489 | 1,338 | 1,274 | 1,064 | 1,313 | 1,115 |
Inventory | 2,353 | 2,016 | 1,958 | 1,434 | 1,559 | 1,597 |
Other Current Assets | 798.68 | 265 | 174.79 | 501.14 | 246.61 | 179.06 |
Total Current Assets | 9,765 | 8,466 | 8,081 | 10,556 | 12,126 | 10,346 |
Property, Plant & Equipment | 5,136 | 5,266 | 5,024 | 4,151 | 3,550 | 2,225 |
Long-Term Investments | 549.17 | 578.87 | 553.26 | 90.88 | 61.75 | 16.95 |
Goodwill | 1,042 | 1,062 | 1,251 | 864.29 | 1,045 | - |
Other Intangible Assets | 1,118 | 1,009 | 1,096 | 995.23 | 1,033 | 265.7 |
Long-Term Accounts Receivable | - | 26.5 | 31.21 | 35.69 | - | - |
Long-Term Deferred Tax Assets | 161.92 | 146.11 | 139 | 175.35 | 211.97 | 122.72 |
Long-Term Deferred Charges | 127.07 | 133.9 | 143.86 | 131.09 | 132.69 | 174.79 |
Other Long-Term Assets | 1,016 | 1,716 | 2,072 | 112.55 | 92.27 | 115.57 |
Total Assets | 18,915 | 18,405 | 18,392 | 17,112 | 18,253 | 13,267 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 1,507 | 1,662 | 1,588 | 1,433 | 1,144 | 770.72 |
Accrued Expenses | 301.61 | 552.92 | 525.58 | 530.34 | 714.42 | 448.46 |
Short-Term Debt | 2,195 | 1,837 | 1,969 | 1,493 | 2,295 | - |
Current Portion of Long-Term Debt | 173.58 | - | 181.13 | 20.14 | 8.01 | - |
Current Portion of Leases | - | 184.9 | 215.05 | 202.66 | 207.31 | 216.18 |
Current Income Taxes Payable | 126.41 | 98.51 | 82.32 | 40.19 | 197.57 | 80.63 |
Current Unearned Revenue | 158.99 | 169.91 | 182.76 | 193.26 | 566.82 | 341.18 |
Other Current Liabilities | 722.47 | 364.08 | 527.9 | 358.47 | 353.78 | 217.57 |
Total Current Liabilities | 5,185 | 4,869 | 5,272 | 4,271 | 5,487 | 2,075 |
Long-Term Debt | 360.86 | 76.99 | 101.54 | 170 | - | - |
Long-Term Leases | 369.17 | 416.88 | 440.88 | 292.01 | 326.46 | 381.81 |
Long-Term Unearned Revenue | 219.85 | 211.16 | 157.15 | 121.65 | 98.79 | 109.63 |
Pension & Post-Retirement Benefits | - | 8.03 | 9.03 | 8.51 | 8.58 | - |
Long-Term Deferred Tax Liabilities | 129.39 | 136.9 | 158.52 | 138.52 | 133.68 | 13.34 |
Other Long-Term Liabilities | 438.14 | 392.93 | 377.48 | - | - | - |
Total Liabilities | 6,702 | 6,112 | 6,516 | 5,002 | 6,055 | 2,580 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 582.97 | 582.33 | 582.33 | 594.39 | 426.49 | 426.49 |
Additional Paid-In Capital | 3,338 | 3,390 | 3,379 | 4,381 | 4,546 | 4,550 |
Retained Earnings | 7,839 | 7,561 | 7,200 | 7,029 | 7,246 | 5,958 |
Treasury Stock | -316.54 | -4.19 | -7.28 | -473.55 | -500.08 | -257.99 |
Comprehensive Income & Other | -49.47 | -11.84 | -2.64 | 2.22 | 0.78 | -1.56 |
Total Common Equity | 11,395 | 11,517 | 11,151 | 11,533 | 11,720 | 10,675 |
Minority Interest | 817.27 | 775.87 | 724.39 | 577.1 | 478.16 | 12.2 |
Shareholders' Equity | 12,212 | 12,293 | 11,876 | 12,110 | 12,198 | 10,687 |
Total Liabilities & Equity | 18,915 | 18,405 | 18,392 | 17,112 | 18,253 | 13,267 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 3,099 | 2,515 | 2,908 | 2,178 | 2,837 | 597.99 |
Net Cash (Debt) | 2,025 | 2,332 | 1,767 | 5,378 | 6,170 | 6,857 |
Net Cash Growth | 85.72% | 32.00% | -67.15% | -12.84% | -10.01% | -15.80% |
Net Cash Per Share | 3.49 | 4.01 | 3.02 | 9.08 | 10.43 | 11.50 |
Filing Date Shares Outstanding | 572.07 | 584.57 | 582.33 | 583.94 | 587.63 | 587.63 |
Total Common Shares Outstanding | 572.07 | 584.57 | 582.33 | 588.14 | 587.63 | 587.63 |
Working Capital | 4,580 | 3,597 | 2,810 | 6,285 | 6,638 | 8,271 |
Book Value Per Share | 19.92 | 19.70 | 19.15 | 19.61 | 19.94 | 18.17 |
Tangible Book Value | 9,235 | 9,446 | 8,804 | 9,674 | 9,642 | 10,409 |
Tangible Book Value Per Share | 16.14 | 16.16 | 15.12 | 16.45 | 16.41 | 17.71 |
Land | - | 2.69 | 2.69 | - | - | - |
Buildings | - | 3,226 | 2,406 | 1,967 | 1,496 | 949.42 |
Machinery | - | 2,675 | 2,389 | 1,983 | 1,863 | 1,238 |
Construction In Progress | - | 511.63 | 1,075 | 984.57 | 765.01 | 216.1 |